Drug recall
Blood and Blood Products for Reprocessing
FDA recall event 81274 · Class III · OneBlood, Inc.
Key facts
| Event ID | 81274 |
|---|---|
| Recall numbers | B-0108-2019 |
| Recalling firm | OneBlood, Inc. |
| Product type | Biologics |
| Products | Blood and Blood Products for Reprocessing |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood product, collected from a donor taking medication containing human pituitary growth hormones, was distributed. |
| Initiation date | Sep 4, 2018 |
| Report date | Nov 21, 2018 |
| Termination date | Nov 14, 2018 |
| City | Orlando |
| State | FL |
| Country | United States |
| FEI number | 1072425 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: